Series C - ArgiNOx Phamaceuticals - Mar 2, 2005 Funding Round Profile - Cointime

Bitcoin $91,683.94 -2.24%
Ethereum $3,319.95 -3.60%
BNB $612.37 -4.10%
Optimism $2.19 -5.83%
Arbitrum $0.87 -6.11%
Solana $230.35 -2.67%
Polygon $0.53 -5.06%
Cosmos $7.96 -0.33%
Avalanche $42.55 +1.33%

Bitcoin $91,683.94 -2.24%
Ethereum $3,319.95 -3.60%
BNB $612.37 -4.10%
Optimism $2.19 -5.83%
Arbitrum $0.87 -6.11%
Solana $230.35 -2.67%
Polygon $0.53 -5.06%
Cosmos $7.96 -0.33%
Avalanche $42.55 +1.33%

ArgiNOx Phamaceuticals

company

Funding Round

Series C

Money Raised

$ 25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Perseus-Soros Biopharmaceutical Fund	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jun 12, 2004	Series B	$ 8M	Perseus-Soros Biopharmaceutical Fund	Detail